Johnson And Johnson Aktie - JNJ

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

135,18

Gebot

134,94

Fragen

135,36

Volumen

11.794

134,00 Tagesbereich 136,90

128,02 52-Wochen-Bereich 161,48

Marktkapitalisierung

325,462B

Handelsende

136,18

Handelsbeginn

134,52

Letzte Trade

135.19999

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

14.817

Ausgegebene Aktien

2.407.616.693

Dividendenrendite

4.18%

Kurs-Gewinn-Verhältnis

26,34

Gewinn pro Aktie (EPS)

5,84

Erlöse

88,82B

Nettogewinn

14,07B

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.jnj.com

Hauptsitz

New Brunswick, New Jersey, USA

Gegründet

Johnson And Johnson is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker JNJ. The last closing price for Johnson And Johnson was 136,18 €. Over the last year, Johnson And Johnson shares have traded in a share price range of 128,02 € to 161,48 €.

Johnson And Johnson currently has 2.407.616.693 shares in issue. The market capitalisation of Johnson And Johnson is 327,87 € billion. Johnson And Johnson has a price to earnings ratio (PE ratio) of 26.34.

Johnson & Johnson to Participate in RBC Capital Markets' Health Care Conference

NEW BRUNSWICK, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Johnson & Johnson will participate in the RBC Capital Markets' Health Care Conference on...

Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes

Cordis to Receive $1.725 Billion BRIDGEWATER, N.J., Feb. 1 /PRNewswire/ -- Cordis Corporation, a Johnson & Johnson company, announced today that...

Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results:

2009 Fourth-Quarter Sales of $16.6 Billion increased 9.0%; EPS was $0.79 2009 Full-Year Sales of $61.9 Billion decreased 2.9%; Full-Year EPS was...

Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2009 Financial Results

NEW BRUNSWICK, N.J., Jan. 19 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday...

Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (ri

TITUSVILLE, N.J., Dec. 10 /PRNewswire/ -- Treatment with once-monthly INVEGA® SUSTENNA(TM) is not inferior to treatment with bi-weekly...

Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses

ORLANDO, Fla., Nov. 11 /PRNewswire-FirstCall/ -- Contact lenses prescribed for longer replacement intervals can lead to more extreme over wear...

VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmolo

Telescope Prosthesis for End-Stage Macular Degeneration Highlighted SARATOGA, Calif., Oct. 20 /PRNewswire/ -- VisionCare Ophthalmic Technologies...

New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis

Patients with Active Rheumatoid Arthritis Receiving SIMPONI Demonstrated Sustained Improvements in Signs and Symptoms Through One Year...

New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis

Results from Radiographic Analyses Show Efficacy of SIMPONI in Inhibiting Joint Destruction in Two Rheumatic Conditions PHILADELPHIA, Oct. 19...

Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Medical Devices & Diagnostics Bu

NEW BRUNSWICK, N.J., Oct. 6 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	1.38	1.03139013453	133.8	139.6	128.02	20162	135.49178617	DE
4	-15.08	-10.035937708	150.26	154.1	128.02	19434	141.02851831	DE
12	-8.1	-5.65326633166	143.28	161.47999	128.02	14817	146.32354878	DE
26	-15.68	-10.3937425428	150.86	161.47999	128.02	11944	145.12508898	DE
52	-3.56	-2.56595069915	138.74	161.47999	128.02	10666	143.4428446	DE
156	-30.8	-18.5564525846	165.98	178.26	128.02	7016	147.5584467	DE
260	0.2	0.148170099274	134.98	178.26	116.12	7709	142.10032818	DE

JNJ - Frequently Asked Questions (FAQ)

What is the current Johnson And Johnson share price?

The current share price of Johnson And Johnson is 135,18 €

How many Johnson And Johnson shares are in issue?

Johnson And Johnson has 2.407.616.693 shares in issue

What is the market cap of Johnson And Johnson?

The market capitalisation of Johnson And Johnson is EUR 327,87B

What is the 1 year trading range for Johnson And Johnson share price?

Johnson And Johnson has traded in the range of 128,02 € to 161,48 € during the past year

What is the PE ratio of Johnson And Johnson?

The price to earnings ratio of Johnson And Johnson is 26,34

What is the cash to sales ratio of Johnson And Johnson?

The cash to sales ratio of Johnson And Johnson is 4,17

What is the reporting currency for Johnson And Johnson?

Johnson And Johnson reports financial results in USD

What is the latest annual turnover for Johnson And Johnson?

The latest annual turnover of Johnson And Johnson is USD 88,82B

What is the latest annual profit for Johnson And Johnson?

The latest annual profit of Johnson And Johnson is USD 14,07B

What is the registered address of Johnson And Johnson?

The registered address for Johnson And Johnson is ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NEW JERSEY, 08933

What is the Johnson And Johnson website address?

The website address for Johnson And Johnson is www.jnj.com

Which industry sector does Johnson And Johnson operate in?

Johnson And Johnson operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
CK1RAREX LTD	0,03 € (106,90%)	59,06k
R8LVolt Resources Limited	0,005 € (78,57%)	52,94k
AZK0Hertz Global Holdings Inc	5,024 € (55,11%)	34,11k
OYM1Odyssey Marine Exploration Inc	0,57 € (53,23%)	83,36k
RK90American Tungsten Corp	0,755 € (38,53%)	65,76k
JJ8ASEP Medical Holdings Inc	0,027 € (-93,86%)	270,1k
EJ7Energy Resources of Australia	0,001 € (-50,00%)	130k
UH7ATennant Minerals NL	0,0035 € (-41,67%)	1,01M
WDL1Nakiki SE	0,12 € (-38,46%)	5,2k
7N1GT Resources Inc	0,012 € (-31,43%)	5k
D7GNel ASA	0,1929 € (-1,88%)	3,43M
4IPParkway Corporate Ltd	0,0056 € (-12,50%)	1,84M
PF8European Lithium Limited	0,0296 € (7,25%)	1,5M
3CPXiaomi Corporation	4,54 € (-7,82%)	1,49M
NVDNVIDIA Corp	91,75 € (-7,68%)	1,48M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Johnson And Johnson (JNJ)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Johnson And Johnson

JNJ Neueste Nachrichten

Johnson & Johnson to Participate in RBC Capital Markets' Health Care Conference

Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes

Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results:

Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2009 Financial Results

Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (ri

Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses

VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmolo

New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis

New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis

Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Medical Devices & Diagnostics Bu

JNJ - Frequently Asked Questions (FAQ)

Beweger

JNJ Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Johnson And Johnson (JNJ) Börsenkurse

Johnson And Johnson (JNJ)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Johnson And Johnson

JNJ Neueste Nachrichten

Johnson & Johnson to Participate in RBC Capital Markets' Health Care Conference

Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes

Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results:

Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2009 Financial Results

Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (ri

Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses

VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmolo

New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis

New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis

Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Medical Devices & Diagnostics Bu

JNJ - Frequently Asked Questions (FAQ)

Beweger

JNJ Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen